retatrutide safety study Efficacy and of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Is Retatrutide Safe for Women?

Async option reduces friction

Customize monitoring to personal health and risk profile and have a knowledgeable clinician interpret

April 16, 2025: Parties in Trulicity Lawsuit to Hold Hearing on Gastroparesis On May 14, 2025, the parties involved in the Trulicity multidistrict litigation will hold a hearing about the reliable diagnostic process for gastroparesis

By combining careful assessment, clear communication, and evolving evidence, clinicians can reduce aspiration risk while maintaining optimal patient outcomes

It does not raise IGF-1 levels

Tirzepatide is FDA-approved under the following brand names: Mounjaro (approved for type 2 diabetes mellitus) Zepbound (approved for chronic weight management and treatment of moderate to severe obstructive sleep apnea) Tirzepatides proven efficacy Tirzepatide is more effective than single-acting GLP-1 medications in achieving significant weight loss